PERIOPERATIVNA NEGA
Management and Optimization of Hemostasis
slovenščina
Management and Optimization of Hemostasis
/assets/ct/28ada02fb0/images/syn_placeholder_sqr.png

Perioperativna nega

Management and Optimization of Hemostasis

Antifibrinolytic Agents

Alternatives to allogeneic platelet transfusion. (odpre novo okno)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Vir‎: Br J Haematol 2016;175(3):381-92.

Tranexamic acid in patients undergoing noncardiac surgery. (odpre novo okno)

Devereaux PJ, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI, Chan MTV, Borges FK, Martínez-Zapata MJ, Wang CY, Xavier D, Ofori SN, Wang MK, Efremov S, Landoni G, Kleinlugtenbelt YV, Szczeklik W, Schmartz D, Garg AX, Short TG, Wittmann M, Meyhoff CS, Amir M, Torres D, Patel A, Duceppe E, Ruetzler K, Parlow JL, Tandon V, Fleischmann E, Polanczyk CA, Lamy A, Astrakov SV, Rao M, Wu WKK, Bhatt K, de Nadal M, Likhvantsev VV, Paniagua P, Aguado HJ, Whitlock RP, McGillion MH, Prystajecky M, Vincent J, Eikelboom J, Copland I, Balasubramanian K, Turan A, Bangdiwala SI, Stillo D, Gross PL, Cafaro T, Alfonsi P, Roshanov PS, Belley-Côté EP, Spence J, Richards T, VanHelder T, McIntyre W, Guyatt G, Yusuf S, Leslie K; POISE-3 Investigators

Vir‎: N Engl J Med. 2022;386(21):1986-97.

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. (odpre novo okno)

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K.

Vir‎: Cochrane Database Syst Rev 2011;(3):CD001886.

Safety and efficacy of tranexamic acid in general surgery. (odpre novo okno)

Park LJ, Marcucci M, Ofori SN, Borges FK, Nenshi R, Kanstrup CTB, Rosen M, Landoni G, Lomivorotov V, Painter TW, Xavier D, Martinez-Zapata MJ, Szczeklik W, Meyhoff CS, Chan MTV, Simunovic M, Bogach J, Serrano PE, Balasubramanian K, Cadeddu M, Yang I, Kim WH, Devereaux PJ

Vir‎: JAMA Surg 2025;160(3):267-74.

Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression. (odpre novo okno)

Taeuber I, Weibel S, Herrmann E, Neef V, Schlesinger T, Kranke P, Messroghli L, Zacharowski K, Choorapoikayil S, Meybohm P

Vir‎: JAMA Surg 2021;156(6):e210884.

Recombinant Activated Factor VII (rFVIIa)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (odpre novo okno)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Vir‎: Transfusion 2009;49 Suppl 5:240S-7S.

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. (odpre novo okno)

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

Vir‎: Circulation 2008;118(4):331-8.

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (odpre novo okno)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Vir‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Coagulation Factor Concentrates

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. (odpre novo okno)

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

Vir‎: Ann Thorac Surg 2009;88(5):1666-8.

Bloodless orthotopic heart transplantation in a Jehovah's Witness. (odpre novo okno)

Dallas T, Welsby I, Bottiger B, Milano C, Daneshmand M, Guinn N.

Vir‎: A A Case Rep 2015;4(10):140-2.

Fibrinogen replacement therapy: a critical review of the literature. (odpre novo okno)

Franchini M, Lippi G.

Vir‎: Blood Transfus 2012;10(1):23-7.

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. (odpre novo okno)

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

Vir‎: Thromb Haemost 2009;102(1):137-44.

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. (odpre novo okno)

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Vir‎: Anesthesiology 2013;118(1):40-50.

Desmopressin

Viscoelastic Tests to Identify Surgical or Coagulopathic Bleeding

Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. (odpre novo okno)

Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, Fries D, Görlinger K, Haas T, Imberger G, Jacob M, Lancé M, Llau J, Mallett S, Meier J, Rahe-Meyer N, Samama CM, Smith A, Solomon C, Van der Linden P, Wikkelsø AJ, Wouters P, Wyffels P.

Vir‎: Eur J Anaesthesiol 2013;30(6):270-382.

Odbori za stike z bolnišnicami (OSB)

Kontaktirajte z lokalnim predstavnikom, ki je brezplačno na voljo zdravnikom, ki zdravijo Jehovove priče.

Kontakt

Paketi informacij za zdravnike

Teme so med drugim: klinični pristopi za preprečevanje in obvladovanje krvavitve in anemije brez transfuzije krvi; verski in etični pogled Jehovovih prič na zdravljenje; storitve, ki jih Jehovove priče nudijo zdravstvenemu osebju po svoji svetovni mreži odborov za stike z bolnišnicami.

Ogled gradiva

Videoposnetki

Zdravnikom, ki zdravijo Jehovove priče, so predstavljene možnosti zdravljenja ter medicinski in etični vidiki.

Ogled videoposnetkov

Intervju s Pio Di Benedetto, dr. med.

»Z dobro premišljenim pristopom in dobro premišljenimi postopki je možno celo zahtevnejše operacije opraviti brez transfuzije krvi.«